Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
120,284,725
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
18,260,665
-
Shares change
-
+678,811
-
Total reported value, excl. options
-
$63,350,669
-
Value change
-
-$15,186,048
-
Put/Call ratio
-
34.85%
-
Number of buys
-
31
-
Number of sells
-
-46
-
Price
-
$3.47
Significant Holders of IMMUNIC, INC. - Common Stock (IMUX) as of Q2 2022
104 filings reported holding IMUX - IMMUNIC, INC. - Common Stock as of Q2 2022.
IMMUNIC, INC. - Common Stock (IMUX) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18,260,665 shares
of 120,284,725 outstanding shares and own 15.18% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (2,761,968 shares), Omega Fund Management, LLC (1,788,160 shares), Point72 Asset Management, L.P. (1,325,000 shares), COWEN AND COMPANY, LLC (1,200,691 shares), MILLENNIUM MANAGEMENT LLC (1,139,154 shares), Lynx1 Capital Management LP (1,104,241 shares), COMMODORE CAPITAL LP (893,013 shares), VANGUARD GROUP INC (879,022 shares), JANUS HENDERSON GROUP PLC (843,817 shares), and Artal Group S.A. (700,000 shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.